WG Biotech ApS - 03 Jun 2021 Form 4 Insider Report for Y-mAbs Therapeutics, Inc. (YMAB)

Role
10%+ Owner
Signature
/s/ Johan Wedell-Wedellsborg
Issuer symbol
YMAB
Transactions as of
03 Jun 2021
Net transactions value
-$1,148,373
Form type
4
Filing time
07 Jun 2021, 16:30:54 UTC
Previous filing
02 Jun 2021
Next filing
09 Jun 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction YMAB Common Stock Sale $1,017,670 -30,666 -0.69% $33.19* 4,415,935 03 Jun 2021 Direct F1
transaction YMAB Common Stock Sale $130,704 -3,841 -0.09% $34.03* 4,412,094 04 Jun 2021 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $33.165 to $34.19. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
F2 This transaction was executed in multiple trades at prices ranging from $34.00 to $34.25. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.